NCT02507349

Brief Summary

Fifteen minutes is the typical length of an outpatient medication management appointment for people with serious mental health conditions. These brief interactions with prescribers are frequently provider-driven with insufficient time focused on the patient's needs and personal recovery. Shared decision making is a strategy that could improve this interaction. This study examines how technology can be used in the care process to amplify the voice of the patient, support shared decisions, and improve treatment outcomes. Investigators will compare the effectiveness of Measurement-Based vs. Person-Centered Care on two primary patient-centered outcomes: the patient experience of care with medication treatment and the level of shared decision making. Investigators hypothesize that:

  1. 1.Person-Centered Care will result in greater improvement in patient experience of care with medication treatment than Measurement-Based Care.
  2. 2.Person-Centered Care will result in a greater level of shared decision making during the medication visit than Measurement-Based Care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,443

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
Completed

Started Aug 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 30, 2015

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 23, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2017

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

February 1, 2019

Completed
Last Updated

February 26, 2019

Status Verified

February 1, 2019

Enrollment Period

2.3 years

First QC Date

June 30, 2015

Results QC Date

January 11, 2018

Last Update Submit

February 6, 2019

Conditions

Keywords

serious mental illnessmental health services researchmeasurement-based careshared decision makingpsychiatric medication managementcommunity psychiatrycomparative effectiveness researchmixed methods research

Outcome Measures

Primary Outcomes (2)

  • Patient Experience of Medication Treatment (PEMM)

    The PEMM is a 12-item self-report measure of mental health patient experience of medication management with prescribers .Response options for 11 questions range from 0=Never to 4=Always, and the response options for the final question range from 0=Very Dissatisfied to 4=Very Satisfied. Overall possible range was 0 to 4. PEMM scores for each time point reflect the mean score of all measures collected within that time frame.

    Baseline and every eight months during the two-year intervention phase

  • Shared Decision Making Questionnaire (SDM-Q-9)

    The SDM-Q-9 is a 9-item self-report measure of the degree of shared decision making in clinical encounters. There are 6 possible responses ranging from: Completely Disagree (0) to Completely Agree (5). Raw score ranges from 0 to 45. Multiplication of the raw score by 20/9 provides a score forced (transformed) to range from 0 to 100, where 0 indicates the lowest possible level of SDM and 100 indicates the highest extent of shared decision making in clinical encounters. SDM-Q-9 scores for each time point reflect the mean score of all measures collected within that time frame.

    Baseline and every eight months during the two-year intervention phase

Secondary Outcomes (8)

  • Hope

    Baseline and every eight months during the two-year intervention phase

  • Medication Side Effects

    Baseline and every eight months during the two-year intervention phase

  • Patient Activation Measure (PAM)

    Baseline and every eight months during the two-year intervention phase

  • Behavior and Symptom Identification Scale (BASIS-24)

    Baseline and every eight months during the two-year intervention phase

  • Sheehan Disability Scale

    Baseline and every eight months during the two-year intervention phase

  • +3 more secondary outcomes

Study Arms (2)

Person-Centered Care

ACTIVE COMPARATOR

Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visit.

Behavioral: Person-Centered Care

Measurement-Based Care

ACTIVE COMPARATOR

Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient.

Behavioral: Measurement-Based Care

Interventions

Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visit.

Person-Centered Care

Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient.

Measurement-Based Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults age 18 and older
  • Non-SMI (anxiety, post-traumatic stress disorder, depression, dysthymia, depression NOS) or SMI (schizophrenia, bipolar disorder, major depression)
  • Receiving services at one of the 15 participating community mental health centers
  • At least three claims for medication management services in past 12 months
  • Insured by Community Care Behavioral Health Organization

You may not qualify if:

  • Assessed by clinicians as being too ill to be treated on an outpatient basis
  • Unable to speak, read, or understand English at the minimum required level

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dartmouth Psychiatric Research Center

Lebanon, New Hampshire, 03766, United States

Location

UPMC Center for High-Value Health Care

Pittsburgh, Pennsylvania, 15219, United States

Location

MeSH Terms

Conditions

SchizophreniaBipolar DisorderDepressive Disorder, Major

Interventions

Patient-Centered Care

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersBipolar and Related DisordersMood DisordersDepressive Disorder

Intervention Hierarchy (Ancestors)

Primary Health CareComprehensive Health CarePatient Care ManagementHealth Services Administration

Limitations and Caveats

The PEMM was developed for this study. For unavoidable reasons, site randomization was not maintained. Data collection timepoints were expanded.

Results Point of Contact

Title
Kelly Williams, Program Administrator
Organization
UPMC Center for High-Value Health Care

Study Officials

  • Gregory J McHugo, PhD

    Dartmouth Psychiatric Research Center, The Geisel School of Medicine at Dartmouth

    PRINCIPAL INVESTIGATOR
  • Kim MacDonald-Wilson, ScD,CRC,CPRP

    UPMC Center for High-Value Health Care

    PRINCIPAL INVESTIGATOR
  • Patricia E Deegan, PhD

    Pat Deegan, PhD & Associates, LLC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Director

Study Record Dates

First Submitted

June 30, 2015

First Posted

July 23, 2015

Study Start

August 1, 2014

Primary Completion

October 31, 2016

Study Completion

March 31, 2017

Last Updated

February 26, 2019

Results First Posted

February 1, 2019

Record last verified: 2019-02

Locations